NeuroZone MSH

LIVE LONGER, FEEL BETTER, THINK CLEARER

COMPANY

Neurozone MSH Inc. is a technology company specializing in providing advanced analytical services for sleep assessment and mental health worldwide.

MISSION

Sleep evaluation for everyone to live longer, feel better, think clearer.

VISION

FOR PATIENTS

Provide access to state of the art sleep testing solutions for everyone

FOR CLIENTS

We are recognized for client service excellence, loyalty and efficiency

FOR COMMUNITIES

We will serve the full range of diverse markets around the world, regardless of economic stature or race. We will help address the epidemic of sleep disorders through increased awareness. Further we will help reduce the stigma attached to mental health.

842

SATISFIED CUSTOMERS

624

LOADED STRATEGIES

69

COUNTRIES WORLDWIDE

436

RECOMMENDATIONS

LATEST NEWS

[the_grid name=”Blog Main”]

OUR

PROFESSIONAL TEAM

DR. LASZLO OSVATH PHD, MSC, SMIEEE, PRESIDENT AND SENIOR SCIENTIST, FOUNDER

Dr. Osvath is an application – oriented scientist with over 19 years of extensive experience in the successful design and implementation of novel algorithms for the medical device industry.
Dr. Osvath worked as a senior scientist developing neuro-diagnostic solutions with focus on epilepsy, long-term monitoring (LTM), neuro-critical care, NICU, sleep and neuro-psychiatry.
These algorithms have been adopted in the workflow of prestigious institutions such as The Mayo clinic, Yale University Hospital, Columbia University Hospital in New York, Rush Chicago, Kings College London UK, Mass Gen., Sick Kids Toronto, London Health Sciences, etc.
At Neurozone MSH he developed Esprit Nova (TM), a unique polysomnography (PSG) system that can be self-applied in the patient’s home and produces results equivalent to the sleep lab. Esprit Nova sets the next frontier in terms of solutions for sleep evaluation i.e. making sleep evaluation available for the population. Dr. Osvath is passionate about the application of analytical methods and technology for the early detection of diseases. Currently his main focus is on finding solutions to address the epidemic of sleep and mental health disorders.

DR. COLIN SHAPIRO BSC(HON), MBBCH, PHD, MRC PSYCH, FRCP(C), PROFESSOR OF PSYCHIATRY AND OPHTHALMOLOGY, DIRECTOR OF YOUTHDALE CHILD AND ADOLESCENT SLEEP CENTER , MEDICAL ADVISOR, FOUNDER

Dr. Shapiro is an internationally recognized academic and researcher. He was the founding president of the International Neuropsychiatry Association, the first president of the British Sleep Society Association, until 2011 was the Director of the Neuropsychiatry programme at the Toronto Western Hospital. Dr. Shapiro was a full professor at the department of psychiatry at the University of Toronto and is the research director of the Youthdale Child and Adolescent Centre.
Dr. Shapiro has a major interest in the basic physiological aspects of sleep, clinical aspects of sleep disorders, the use of sleep recordings for diagnostic purposes and the prospect of using sleep related measures in psychiatry specifically in depression. He also has an interest in chronobiology as it relates to psychiatry and pharmacology.
Some of his numerous accomplishments:
• Director of first sleep laboratory in Africa
• First President of the British Sleep Society
• Founding President of the International Neuropsychiatric Association
• Over 300 publications in refereed journals
• Over 15 published books
• Awarded James McHarg prize by the Royal College of Psychiatrists

DR. ADAM MOSKOVITCH M.D, FRCPC, DABSM, DABPN, DABFM, DABFE, MEDICAL DIRECTOR

Dr. Moscovitch is a leading internationally recognized expert on sleep and fatigue disorders. In 1995, he founded the Canadian Sleep Institute, a comprehensive center of excellence dedicated to clinical care, research and corporate consulting on sleep and fatigue problems, and was its Medical Director and owner till early 2010. He is certified in General Medicine and holds specialty Certifications in Sleep Medicine, Psychiatry, Neurology, and Forensic Medicine. Dr Moscovitch founded the Fatigue Solutions Inc, a consulting firm, specializing in Fatigue Management in 24/7 type of operations.
He is the recipient of the 2004 Outstanding Clinical Researcher of the Year Award, Department of Psychiatry, University of Calgary.
Specialties: Sleep and Fatigue Disorders, Medico-Legal aspects of Sleep and Fatigue, Psychopharmacology, Sleep and Pain, Sleep and the elderly
Diplomate, American Board of Sleep Medicine
Diplomate, American Board of Psychiatry and Neurology
Diplomate, American Board of Forensic Medicine

SLEEP INFO

“Poor sleep should be considered a risk factor for cardiovascular disease along with smoking, lack of exercise and poor diet.”

European Society of Cardiology

‘Sleep problems affect up to 45 per cent of the world’s population’

World Association of Sleep Medicine

’50 to 70 million Americans chronically suffer from a disorder of sleep and wakefulness, hindering daily functioning and adversely affecting health and longevity.’

Institute of Medicine of The National Academies

‘The cumulative long-term effects of sleep loss and sleep disorders have been associated with a wide range of deleterious health consequences including an increased risk of hypertension, diabetes, obesity, depression, heart attack, and stroke.’

Institute of Medicine of The National Academies

Economic cost of insufficient sleep

THE SOLUTION

The solution for detecting sleep disorders and reducing the health and economic consequences thereof is through the implementation of sleep screening programs

By adopting the Esprit Nova system in their workflow, sleep laboratories can test larger segments of the population at home, while in the lab can concentrate on more specialized aspects that cannot be addressed elsewhere.

The only way to implement screening programs for sleep disorders is through the adoption of low-cost, high-efficiency testing solutions that are equivalent to tests performed in the lab.

We envision an interdisciplinary approach for identification and treatment of sleep disorders.

SERVICES

THE ESPRIT NOVA SYSTEM

The next frontier in at-home sleep evaluation

Esprit Nova is a unique model for sleep testing in the patient’s home that permits health care practitioners and sleep monitoring companies to operate much more efficiently. Our system is scalable, permitting any number of clients to perform in parallel any number of tests, 24/7, anywhere.

Esprit Nova is the first and only accessible sleep screening technology which covers all aspects of sleep and produces a report equivalent to the sleep lab. Additional parameters beyond the standard ones are available for researchers. The results are available in 24-48 hours.

Esprit Nova can also reach the areas with no access currently to sleep labs. With our system people with disabilities can have a sleep test done in their homes.

Unique model of sleep testing in the patient’s home

Unlimited number of clients
.

Unlimited number of tests
.

Unlimited business scalability
.

<

CLIENTS

Neurozone is a technology company, not a sleep lab. If you are a patient interested in having a sleep test in your home, please ask your primary health care provider, or local sleep lab if Neurozone at-home sleep testing is available in your region.

Neurozone provides cutting-edge technologies for sleep testing at any scale (from small lab to national programmes). Whether you are a sleep lab and want to expand your business, or consider to start a sleep testing operation, Neurozone MSH is the right choice for you.

Neurozone MSH offers a turn-key solution for at-home sleep testing using Esprit Nova.
To become a Neurozone MSH partner, contact us to discuss your plans.

Let’s Work On Your Next Project Together !

CONTACT US

DISCOVER OUR RECENT

COMPLETED PROJECTS

[the_grid name=”Potfolio Gallery”]

What would life be if we had no courage to attempt anything?

Vincent van Gogh

NEUROZONE MSH

CONTACT

EMAIL

info@neurozonemsh.com

19$per month

Projects
4 users
5 GB Space